Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00876889 · ClinicalTrials.gov registry record
Safety of Riluzole in Patients With Acute Spinal Cord Injury
A clinical trial, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 36
- Enrollment target
NCT00876889 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 36 participants.
The verdict
NCT00876889 has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to find out if the use of the drug Riluzole is both safe and improves outcome in patients with acute traumatic spinal cord injury (SCI).
Interventions
- DRUG Riluzole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00876889
The ClinicalTrials.gov registry entry for NCT00876889 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Riluzole is the first listed.
NCT00876889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00876889 about?
NCT00876889 is a clinical study titled "Safety of Riluzole in Patients With Acute Spinal Cord Injury". The purpose of the study is to find out if the use of the drug Riluzole is both safe and improves outcome in patients with acute traumatic spinal cord injury (SCI).
What is the current status of trial NCT00876889?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2010-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00876889?
The interventions under investigation include: Riluzole (DRUG).
Who is sponsoring clinical trial NCT00876889?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.